Third line chemotherapy in patients with metastatic breast cancer: an evaluation of quality of life and cost.
- 1 April 1999
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 54 (3) , 213-223
- https://doi.org/10.1023/a:1006123721205
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The “utility” of the time trade-off method in cancer patients: Feasibility and proportional trade-offJournal of Clinical Epidemiology, 1995
- Approaches to the analysis of quality of life data: experiences gained from a Medical Research Council Lung Cancer Working Party palliative chemotherapy trialQuality of Life Research, 1994
- A validation study of the domains of the core EORTC Quality of Life QuestionnaireQuality of Life Research, 1993
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Psychometric Validation of the Eortc Core Quality of Life Questionnaire, 30-Item Version and A Diagnosis-Specific Module for Head and Neck Cancer PatientsActa Oncologica, 1992
- Cisplatin and Etoposide: An Effective Treatment for Refractory Breast CarcinomaAmerican Journal of Clinical Oncology, 1989
- Improving the Quality of Life during Chemotherapy for Advanced Breast CancerNew England Journal of Medicine, 1987
- Measurement of health state utilities for economic appraisalJournal of Health Economics, 1986
- Eliciting Preferences for Alternative Cancer Drug TreatmentsMedical Decision Making, 1985
- Comparative trial of endocrine versus cytotoxic treatment in advanced breast cancer.BMJ, 1977